Shengdi Wu

1.5k total citations
44 papers, 1.1k citations indexed

About

Shengdi Wu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Shengdi Wu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 20 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Shengdi Wu's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease and Transplantation (8 papers). Shengdi Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease and Transplantation (8 papers). Shengdi Wu collaborates with scholars based in China, United States and Canada. Shengdi Wu's co-authors include Xizhong Shen, Yu‐Shui Ma, Wei Jiang, Ying Fang, Da Fu, Ling Dong, Hao Wu, Taotao Liu, Nan Lü and Hai‐Ning Liu and has published in prestigious journals such as Biomaterials, Frontiers in Microbiology and Transplantation.

In The Last Decade

Shengdi Wu

43 papers receiving 1.1k citations

Peers

Shengdi Wu

EPIDE

HEPAT

IMMUN

SURGE

Miriam Ruth Bueno‐Topete Mexico

Yung‐Yu Hsieh Taiwan

Linda E. Muñoz‐Espinosa Mexico

Myoung-Kuk Jang South Korea

Shuji Kanmura Japan

Ali Mencin United States

Atsushi Naganuma Japan

Masahiko Tameda Japan

Fernando Alegre Spain

Miriam Ruth Bueno‐Topete Mexico

Shengdi Wu

327 ×0.8

EPIDE

263 ×0.7

330 ×1.2

HEPAT

148 ×0.8

IMMUN

96 ×0.7

SURGE

Citations per year, relative to Shengdi Wu Shengdi Wu (= 1×) peers Miriam Ruth Bueno‐Topete

Countries citing papers authored by Shengdi Wu

Since Specialization

Citations

This map shows the geographic impact of Shengdi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengdi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengdi Wu more than expected).

Fields of papers citing papers by Shengdi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengdi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengdi Wu. The network helps show where Shengdi Wu may publish in the future.

Co-authorship network of co-authors of Shengdi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengdi Wu. A scholar is included among the top collaborators of Shengdi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengdi Wu. Shengdi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Nannan, Haitao Ge, Chuantao Tu, et al.. (2025). Development and validation of machine learning models to predict esophagogastric variceal rebleeding risk in HBV-related cirrhosis after endoscopic treatment: a prospective multicenter study. EClinicalMedicine. 87. 103436–103436.

Yang, Yanping, Maosong Ye, Yijun Song, et al.. (2025). Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC. npj Biofilms and Microbiomes. 11(1). 146–146. 5 indexed citations

Shen, Yue, et al.. (2023). Immune modulation of gut microbiota and its metabolites in chronic hepatitis B. Frontiers in Microbiology. 14. 1285556–1285556. 4 indexed citations

Chen, Hong, et al.. (2023). Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis. World Journal of Gastroenterology. 29(39). 5503–5525. 7 indexed citations

Wang, Fusheng, Yaobing Chen, Hao Chen, et al.. (2022). Virtual liver needle biopsy from reconstructed three-dimensional histopathological images: Quantification of sampling error. Computers in Biology and Medicine. 147. 105764–105764. 6 indexed citations

Wu, Shengdi, et al.. (2019). High Mobility Group Box 1: An Immune-regulatory Protein. Current Gene Therapy. 19(2). 100–109. 8 indexed citations

Shen, Yue, Shengdi Wu, Ling Wu, et al.. (2019). The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose–response meta-analysis. Hepatology International. 13(5). 560–572. 26 indexed citations

Liu, Yun, et al.. (2019). Predictors of relapse after cessation of nucleos(t)ide analog treatment in HBeAg-negative chronic hepatitis B patients: A meta-analysis. International Journal of Infectious Diseases. 86. 201–207. 20 indexed citations

Wu, Shengdi, et al.. (2018). Evaluation of transient elastography in assessing liver fibrosis in patients with advanced schistosomiasis japonica. Parasitology International. 67(3). 302–308. 13 indexed citations

10.

Wu, Shengdi, Hong Ding, Li‐Li Liu, et al.. (2017). Longitudinal monitoring of liver stiffness by acoustic radiation force impulse imaging in patients with chronic hepatitis B receiving entecavir. Clinics and Research in Hepatology and Gastroenterology. 42(3). 227–236. 3 indexed citations

11.

Yang, Cheng, Shengdi Wu, Sheng Zhou, et al.. (2014). A Novel Simple Noninvasive Index to Predict Renal Transplant Acute Rejection by Contrast-Enhanced Ultrasonography. Transplantation. 99(3). 636–641. 48 indexed citations

12.

Wu, Shengdi, Lei Li, & Jiyao Wang. (2012). Ursodeoxycholic acid for nonalcoholic steatohepatitis. European Journal of Gastroenterology & Hepatology. 24(11). 1–1. 11 indexed citations

13.

Huang, Yingnan, Hao Wu, Shengdi Wu, et al.. (2012). A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B. Digestive Diseases and Sciences. 58(3). 815–823. 5 indexed citations

14.

Li, Lei, et al.. (2012). MTHFR Polymorphisms and Pancreatic Cancer Risk:Lack of Evidence from a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 13(5). 2249–2252. 3 indexed citations

15.

Zhao, Yuan, Yu‐Shui Ma, Ying Fang, et al.. (2011). IGF2BP2 Genetic Variation and Type 2 Diabetes: A Global Meta-Analysis. DNA and Cell Biology. 31(5). 713–720. 15 indexed citations

16.

Wang, Yi, Yu‐Shui Ma, Ying Fang, et al.. (2011). Regulatory T cell: a protection for tumour cells. Journal of Cellular and Molecular Medicine. 16(3). 425–436. 59 indexed citations

17.

Wu, Shengdi, Yu‐Shui Ma, Ying Fang, et al.. (2011). Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treatment Reviews. 38(3). 218–225. 98 indexed citations

18.

Zhao, Yuan, Yu‐Shui Ma, Ying Fang, et al.. (2011). Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies. Molecular Genetics and Metabolism. 105(1). 141–148. 58 indexed citations

19.

Wu, Shengdi. (2010). Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study. World Journal of Gastroenterology. 16(4). 501–501. 43 indexed citations

20.

Wu, Shengdi. (1958). Intercellular Migration of Nucleus in Somatic Tissues. Journal of Integrative Plant Biology. 7(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact